BioPharma Credit Supports Amicas Acquisition of 10 Gene Therapies

Amicus Therapeutics signed an agreement to obtain worldwide development and commercial rights for 10 gene therapy programs. BioPharma Credit provided a $150 million term loan to support the purchase.

MidCap, Oxford and SVB Complete Amicus Therapeutics Debt Financing

Amicus Therapeutics announced it completed a $25 million, long-term debt financing with a lending syndicate consisting of MidCap Financial, Oxford Finance and Silicon Valley Bank.